Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Commentary|Podcasts|October 25, 2024
The Impact of RFID: Enhancing Medication Management
Author(s)Nicholas Saraceno, Senior Editor
Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.
Advertisement
In this exclusive PC Podcast interview, Rob Sobie, chief product officer of Intelliguard, a provider of hospital medication management and data intelligence solutions, discusses:
- The key challenges that hospitals are currently facing
- Why he believes that the drug supply chain is failing
- Successes surrounding the implementation of RFID technology
- A high-level overview of the Drug Supply Chain Security Act, along with his thoughts on the latest exemptions that were recently announced by the FDA
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Advertisement
Related to this article
AI-native operating systems present new capabilities to improve pharma supply chain operations.
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Episode 3 of Supply Chain Signal examines the Aug. 31 MFN agreements with nine mid-size manufacturers, the GENEROUS Medicaid model and whether pricing, trade and manufacturing policy now add up to a new pharma operating model.
Cencora's Ameer Ali on the operational lift behind the 12-digit NDC shift, the readiness gap across manufacturers and what's at stake for product flow if systems aren't ready in time.
Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
Valerie Bandy of Tecsys on where 340B rebate mechanics threaten pharmacy purchasing, and how stakeholders can prevent disruption.
Informa's invitation-only Leadership Summit returns to CPHI Milan Oct. 6 as executives weigh sourcing, medicine security and reshoring pressure.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FAQ: What Comes Next for the 340B Rebate Pilot
2
How Early Development Decisions Shape Commercial Readiness for Biologics
3
Why Early, Big-Picture Planning Is Key to Execution Across the CGT Lifecycle
4
Pharma Pulse: Vicapsys-Stateline Merger and Veritiv's TempSafe RxShield
5